Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
Want to see HK:1652 full AI Analyst Report?
Total Valuation
Fusen Pharmaceutical Co., Ltd. has a market cap or net worth of HK$823.45M. The enterprise value is HK$959.02M.
Market CapHK$823.45M
Enterprise ValueHK$959.02M
Share Statistics
Fusen Pharmaceutical Co., Ltd. has 739,301,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding739,301,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Fusen Pharmaceutical Co., Ltd.’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -0.24%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-0.24%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee241.70K
Profits Per Employee-10.15K
Employee Count1,131
Asset Turnover0.22
Inventory Turnover1.67
Valuation Ratios
The current PE Ratio of Fusen Pharmaceutical Co., Ltd. is ―. Fusen Pharmaceutical Co., Ltd.’s PEG ratio is 0.48.
PE Ratio―
PS Ratio1.94
PB Ratio1.48
Price to Fair Value1.48
Price to FCF7.59
Price to Operating Cash Flow6.35
PEG Ratio0.48
Income Statement
In the last 12 months, Fusen Pharmaceutical Co., Ltd. had revenue of 273.37M and earned -11.78M in profits. Earnings per share was -0.02.
Revenue273.37M
Gross Profit109.79M
Operating Income-1.72M
Pretax Income-7.60M
Net Income-11.78M
EBITDA25.55M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was 123.56M and capital expenditures -49.04M, giving a free cash flow of 58.78M billion.
Operating Cash Flow123.56M
Free Cash Flow58.78M
Free Cash Flow per Share0.08
Dividends & Yields
Fusen Pharmaceutical Co., Ltd. pays an annual dividend of HK$0.004, resulting in a dividend yield of ―
Dividend Per ShareHK$0.004
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.07
52-Week Price Change286.21%
50-Day Moving Average1.19
200-Day Moving Average0.82
Relative Strength Index (RSI)45.33
Average Volume (3m)1.23M
Important Dates
Fusen Pharmaceutical Co., Ltd. upcoming earnings date is Sep 2, 2026, TBA (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
Fusen Pharmaceutical Co., Ltd. as a current ratio of 0.56, with Debt / Equity ratio of 90.25%
Current Ratio0.56
Quick Ratio0.45
Debt to Market Cap0.61
Net Debt to EBITDA9.41
Interest Coverage Ratio-0.09
Taxes
In the past 12 months, Fusen Pharmaceutical Co., Ltd. has paid 4.20M in taxes.
Income Tax4.20M
Effective Tax Rate-0.55
Enterprise Valuation
Fusen Pharmaceutical Co., Ltd. EV to EBITDA ratio is 30.20, with an EV/FCF ratio of 11.03.
EV to Sales2.82
EV to EBITDA30.20
EV to Free Cash Flow11.03
EV to Operating Cash Flow6.33
Balance Sheet
Fusen Pharmaceutical Co., Ltd. has HK$83.88M in cash and marketable securities with HK$324.34M in debt, giving a net cash position of -HK$240.46M billion.
Cash & Marketable SecuritiesHK$83.88M
Total DebtHK$324.34M
Net Cash-HK$240.46M
Net Cash Per Share-HK$0.33
Tangible Book Value Per ShareHK$0.47
Margins
Gross margin is 40.16%, with operating margin of -0.63%, and net profit margin of -4.31%.
Gross Margin40.16%
Operating Margin-0.63%
Pretax Margin-2.78%
Net Profit Margin-4.31%
EBITDA Margin9.35%
EBIT Margin-3.34%
Analyst Forecast
The average price target for Fusen Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-15.98%
EPS Growth Forecast93.93%